Skip to main content

Volume 18 Supplement 2

Rethinking the pros and cons of randomized controlled trials and observational studies in the era of big data and advanced methods: A panel discussion

Proceedings

Publication of this supplement has been supported by funding from a Canadian Institutes of Health Research Grant

Virtual24th February 2022

Meeting recording

Editor: Simon Décary, Université de Sherbrooke

  1. Randomized controlled trials (RCTs) have traditionally been considered the gold standard for medical evidence. However, in light of emerging methodologies in data science, many experts question the role of RCT...

    Authors: Pamela Fernainy, Alan A. Cohen, Eleanor Murray, Elena Losina, Francois Lamontagne and Nadia Sourial
    Citation: BMC Proceedings 2024 18(Suppl 2):1
    Content type: Meeting report Published on:

    The Correction to this article has been published in BMC Proceedings 2024 18:16

New Content Item

Follow

Annual Journal Metrics

  • Citation Impact 2023
    Source Normalized Impact per Paper (SNIP): 0.893
    SCImago Journal Rank (SJR): 0.475

    Usage 2023
    Downloads: 640,615
    Altmetric mentions: 196

BMC Proceedings

ISSN: 1753-6561

Contact us